Late-breaking data from Abbott's groundbreaking first-in-human study demonstrated successful implantation of the company's AVEIR Conduction System Pacing (CSP) leadless pacemaker Enrollment has also begun in the ASCEND CSP pivotal clinical trial to evaluate Abbott's investigational CSP...
Read More Details
Finally We wish PressBee provided you with enough information of ( Abbott Highlights New AVEIR™ Data, Initiates Trial for the Company's Conduction System Pacing Technology )
Also on site :
- Petroleum Ministry activates emergency plan for natural gas supply
- Amazon Is Selling a 'Buttery Soft' $60 2-Piece Set for Just $30, and Shoppers Say It 'Feels Like Spanx Air Essentials'
- How to watch the No Kings protests taking place around the country